These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36509537)

  • 21. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L; Swan N; Hughes DJ
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
    Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.
    Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR
    Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
    Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
    Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of double-contrast barium enema in colorectal cancer screening based on fecal occult blood.
    Ciatto S; Castiglione G
    Tumori; 2002; 88(2):95-8. PubMed ID: 12088265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of the OC Sensor
    Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
    Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing.
    Maeda Y; Gray E; Figueroa JD; Hall PS; Weller D; Dunlop MG; Din FVN
    BJS Open; 2021 Jul; 5(4):. PubMed ID: 34228096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancing Colorectal Cancer Screening with Droplet Digital PCR Analysis of Fusobacterium nucleatum in Fecal Immunochemical Test Samples.
    Datorre JG; Dos Reis MB; de Carvalho AC; Porto J; Rodrigues GH; Lima AB; Reis MT; Hirai W; Hashimoto CL; Guimarães DP; Reis RM
    Cancer Prev Res (Phila); 2024 Oct; 17(10):471-479. PubMed ID: 38953141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
    Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
    Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DIAGNOSTIC ACCURACY OF ONE SAMPLE OR TWO SAMPLES QUANTITATIVE FECAL IMMUNOCHEMICAL TESTS FOR INTESTINAL NEOPLASIA DETECTION.
    Mattar R; Marques SB; Minata MK; Silva-Etto JMKD; Sakai P; DE Moura EGH
    Arq Gastroenterol; 2020; 57(3):316-322. PubMed ID: 32935747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
    Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
    Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer.
    Wong CK; Fedorak RN; Prosser CI; Stewart ME; van Zanten SV; Sadowski DC
    Int J Colorectal Dis; 2012 Dec; 27(12):1657-64. PubMed ID: 22696204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening.
    Parra-Blanco A; Gimeno-García AZ; Quintero E; Nicolás D; Moreno SG; Jiménez A; Hernández-Guerra M; Carrillo-Palau M; Eishi Y; López-Bastida J
    J Gastroenterol; 2010 Jul; 45(7):703-12. PubMed ID: 20157748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia.
    Haug U; Kuntz KM; Knudsen AB; Hundt S; Brenner H
    Br J Cancer; 2011 May; 104(11):1779-85. PubMed ID: 21559011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Head-to-head comparison of the test performance of self-administered qualitative vs. laboratory-based quantitative fecal immunochemical tests in detecting colorectal neoplasm.
    Lu M; Zhang YH; Lu B; Cai J; Liu CC; Chen HD; Dai M
    Chin Med J (Engl); 2021 May; 134(11):1335-1344. PubMed ID: 34039863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of a single qualitative immunochemical fecal occult blood test coupled with physical measurements.
    Wu T; Kuo K; Wu Y; Lin K
    Chin Med J (Engl); 2014; 127(24):4164-70. PubMed ID: 25533816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Findings from the first colorectal cancer screening among 103 542 individuals in Vietnam with systematic review of colorectal cancer screening programs in Asia-Pacific region.
    Tran CT; Nguyen MV; Tran MT; Tuong TT; Tran QH; Le LC; Pham HT; Bui NC; Vu HH; Nguyen TT; Ta PQ; Ha HT; Trinh DT; Bui HT; Trinh DQ; Van Nguyen K; Le SH; Van Vu K; Van Tran T; Tran HT; Shrubsole MJ; Ye F; Cai Q; Zheng W; Boffetta P; Shu XO; Luu HN
    Jpn J Clin Oncol; 2022 Jul; 52(7):707-715. PubMed ID: 35383373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing sampling device for the fecal immunochemical test increases colonoscopy yields in colorectal cancer screening.
    Huang Y; Li Q; Ge W; Hu Y; Cai S; Yuan Y; Zhang S; Zheng S
    Eur J Cancer Prev; 2016 Mar; 25(2):115-22. PubMed ID: 25768975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood test.
    Ferlitsch M; Heinze G; Salzl P; Britto-Arias M; Waldmann E; Reinhart K; Bannert C; Fasching E; Knoflach P; Weiss W; Trauner M; Ferlitsch A
    Med Oncol; 2014 Sep; 31(9):151. PubMed ID: 25115743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.